We ARE MOVING. New address effective July 6: #100 – 119 14 St. NW, Calgary, AB T2N 1Z6, Canada.
Search
0

CLIA-Certified Cytokine Testing for Physicians and Referring Labs

/ CLIA-Certified Cytokine Testing for Physicians and Referring Labs

Looking for clinical cytokine testing options?

Eve Technologies provides clinical diagnostic testing through Eve Diagnostics, our CLIA-certified clinical laboratory division.

Eve Diagnostics is CLIA-certified for high-complexity testing in General Immunology (CLIA# 99D2283230), holds CDPH certification, and offers Laboratory Developed Tests (LDTs) in General Immunology. Our clinical menu includes one of the most comprehensive cytokine, chemokine and growth factor testing options available for physicians and referring laboratories, with competitive pricing and clinical laboratory quality.

View All Diagnostic Tests
Learn more about Eve Diagnostics

Cytokine Testing in a Clinical Laboratory Setting

Clinical cytokine testing gives physicians and referring laboratories access to immune biomarker data from patient specimens. Depending on the test ordered, that may mean a single-analyte assay such as IL-6, a focused cytokine panel, or a broader cytokine, chemokine, and growth factor profile. Cytokines are best understood as biomarkers: measured characteristics that reflect biological processes or responses to an exposure or intervention, not stand-alone measures of how a patient feels, functions, or survives [1]. 

For patient-specific clinical results, cytokine testing belongs in the appropriate clinical laboratory pathway. In the United States, that means CLIA-regulated testing. Outside the U.S., patient-specific testing likewise requires the appropriate national or ISO 15189-based accreditation framework [2][3]. 

What cytokines and cytokine biomarkers tell you

Cytokines are important mediators of cell-to-cell communication in both the innate and adaptive immune systems. Their effects can vary depending on the cytokine measured, the cellular target, the timing of collection, and the broader clinical context [4]. This is why clinical cytokine testing is usually most informative when results are reviewed as part of a wider laboratory and clinical picture, rather than as isolated values.

A practical way to understand cytokine testing is as a form of immune biomarker testing. Depending on the assay or panel ordered, cytokine results may help providers review inflammatory signaling, immune activation patterns, or broader immune signatures alongside the patient’s history, physical examination, and other laboratory findings.

Because cytokines are biomarkers, not stand-alone diagnostic answers, clinical laboratory sources use cautious interpretation language. Important: cytokine testing should not be used by itself to establish or exclude a specific diagnosis.

Clinical cytokine testing vs research cytokine testing

Clinical cytokine testing and research cytokine testing may measure many of the same immune biomarkers, but they are not interchangeable. The key difference is the intended use of the result.

In the United States, CMS explains that CLIA applies when a laboratory reports patient-specific results that are made available for diagnosis, prevention, treatment, or health assessment. Research testing that does not report patient-specific results is handled differently [2][3].

Because of this, a cytokine assay used in a research study and a clinical cytokine test may involve similar biology, analytes, or technologies, but they serve different purposes. If cytokine results are being reported for an individual patient and reviewed by a healthcare professional, the testing should follow the appropriate clinical laboratory pathway. In the U.S., that means testing through a laboratory with the appropriate CLIA certificate before accepting human specimens for clinical testing [3].

Why CLIA matters for patient-specific results

For patient-specific clinical testing in the United States, CLIA certification is an important part of the laboratory framework. CMS states that the objective of CLIA is to help ensure laboratory testing is accurate, reliable, and timely [2].

For physicians and referring laboratories, this matters because clinical cytokine testing is highly method- and specimen-sensitive. Cytokine results can be affected by the assay method, specimen type, processing time, storage conditions, shipping temperature, and laboratory validation process. In clinical testing, quality systems, validated workflows, specimen handling requirements, and reporting procedures all help determine whether a result is appropriate for patient-specific review.

Eve Diagnostics provides cytokine testing through a CLIA high-complexity clinical laboratory workflow. Its clinical cytokine assays are Laboratory Developed Tests, and the ordering process is structured for physician and referring-lab use, including patient information, referring provider details, and ordering laboratory information to support timely accessioning and reporting [5].

Single-analyte, focused, and comprehensive cytokine panels

Not every order needs the same level of breadth.

Clinical cytokine testing can range from a single biomarker to a broad multiplex panel. The right format depends on what the ordering provider or referring laboratory needs to measure, the specimen requirements, and the validated test menu of the performing laboratory.

A single-analyte assay is the most targeted option. It measures one cytokine or immune biomarker.

A focused cytokine panel measures a limited group of related cytokines or immune biomarkers. This option can provide more information than a single-analyte test while keeping the panel targeted.

A comprehensive cytokine panel provides broader immune biomarker coverage from one specimen workflow. Eve Diagnostics’ current clinical menu includes a Comprehensive Cytokine, Chemokine, Growth Factor 95-Plex panel, along with focused cytokine, soluble receptor, complement, angiogenesis, and vascular/inflammation panels [6].

For physicians and referring laboratories comparing clinical cytokine testing options, the 95-Plex panel is one of the most comprehensive clinical cytokine, chemokine, and growth factor panel options available. It is designed to provide broad immune biomarker data through a CLIA-certified clinical testing pathway while offering a cost-effective alternative to ordering many individual cytokine assays separately [6].

Why multiplex testing matters

Multiplex cytokine testing measures multiple analytes in parallel from the same specimen. That matters operationally because it can preserve sample, reduce multiple separate send-out orders, and provide broader biomarker coverage from one workflow.

But multiplexing is not the same as interchangeability. A 2025 paper comparing multiple cytokine platforms found strong correlations for some analytes across platforms, but also meaningful differences in absolute concentrations and sensitivity, supporting a fit-for-purpose approach rather than assuming all multiplex platforms behave the same. Likewise, earlier multisite work showed that multiplex assays can differ in reproducibility across labs and lots. In practical terms, providers should interpret results in the context of the specific performing lab, matrix, and validated method. 

At Eve Diagnostics, the current requisition already reflects the main ordering workflow that physicians and referring laboratories care about: required patient/referring-lab fields, shipping timing guidance, and a note that results typically follow within 5 business days after receipt of sample [6].

References

  1. Centers for Medicare & Medicaid Services. Clinical Laboratory Improvement Amendments (CLIA). Available at: https://www.cms.gov/medicare/quality/clinical-laboratory-improvement-amendments.
  2. International Organization for Standardization. ISO 15189:2022: Medical laboratories — Requirements for quality and competence. 4th ed. Geneva: International Organization for Standardization; 2022. Available at: https://www.iso.org/standard/76677.html.
  3. FDA-NIH Biomarker Working Group. BEST (Biomarkers, EndpointS, and other Tools) Resource: Glossary. Silver Spring, MD: Food and Drug Administration; Bethesda, MD: National Institutes of Health; 2016. Updated January 16, 2025. Available at: https://www.ncbi.nlm.nih.gov/books/NBK338448/.
  4. National Library of Medicine. PubMed record: PMID 39808132. Bethesda, MD: National Library of Medicine. Available at: https://pubmed.ncbi.nlm.nih.gov/39808132/.
  5. Eve Diagnostics. Eve Diagnostics: Clinical Diagnostic Testing. Available at: https://evediagnostics.com/.
  6. Eve Diagnostics. Cytokine, Chemokine, and Growth Factor Panel (95-Plex). Available at: https://evediagnostics.com/diagnostic-tests/comprehensive-cytokine-chemokine-and-growth-factor-profile/.